Arterial hypertension and stroke prevention: an update (Q36533147)

14 August 2017

1 reference

title

Arterial hypertension and stroke prevention: an update (English)

1 reference

14 August 2017

arterial hypertension

1 reference

4

Lucilla Parnetti

1 reference

14 August 2017

Natan Bornstein

1

1 reference

PubMed ID

16833041

14 August 2017

Giorgio Silvestrelli

series ordinal

2

1 reference

PubMed ID

16833041

14 August 2017

Valeria Caso

series ordinal

3

1 reference

14 August 2017

1 April 2006

1 reference

Clinical and Experimental Hypertension

14 August 2017

1 reference

14 August 2017

28

1 reference

14 August 2017

3-4

1 reference

14 August 2017

317-326

1 reference

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

14 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Cardiovascular protection and blood pressure reduction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

New horizons for stroke prevention: PROGRESS and HOPE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : a critical review of current scientific evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Progressive resistance exercise and resting blood pressure : A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960600549405

10.1080/10641960600549405

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16833041